Drug Class Description
Dipeptidyl peptidase 4 (DPP-4) inhibitors
Generic Name
Vildagliptin
Drug Description
Each tablet contains 50mg of vildagliptin.Excipient: Each tablet contains 47.82mg anhydrous lactose
Presentation
TabletWhite to light yellowish, round (8mm diameter), flat-faced, bevelled-edge tablet. One side is debossed with “NVR”, and the other side with “FB”.
Indications
Vildagliptin is indicated in the treatment of type 2 diabetes mellitus: As dual oral therapy in combination with:
• metformin, in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin
• a sulphonylurea, in patients with insufficient glycaemic control despite maximal tolerated dose of a sulphonylurea and for whom metformin is inappropriate due to contraindications or intolerance
• a thiazolidinedione, in patients with insufficient glycaemic control and for whom the use of a thiazolidinedione is appropriate.
Adult Dosage
Adults
